"???This legislation incentivizes and encourages capital formation for small, emerging biotechnology companies, speeding the development of new cures and treatments for patients living with debilitating diseases such as cancer, diabetes, Parkinson???s, and HIV/AIDS,??? BIO President and CEO Jim Greenwood said in a statement soon after the JOBS Act???s passage." . . . .